Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Mol Cell Probes ; 21(4): 257-66, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17329079

RESUMO

In the cat genome, endogenous feline leukemia virus (enFeLV) exists as multiple, nearly full-length proviral sequences. Even though no infectious virus is produced from enFeLV sequences, transcription and translation have been demonstrated in tissues of healthy cats and in feline cell lines. To test the hypothesis that the enFeLV loads play a role in exogenous FeLV-A infection and pathogenesis, we designed three real-time PCR assays to quantify U3 and env enFeLV loads (two within U3 amplifying different sequences; one within env). Applying these assays, we investigated the loads in blood samples derived from Swiss privately owned domestic cats, specific pathogen-free (SPF) cats and European wildcats (Felis silvestris silvestris). Significant differences in enFeLV loads were observed between privately owned cats and SPF cats as well as among SPF cats originating from different catteries and among domestic cats of different breeds. Within privately owned cats, FeLV-infected cats had higher loads than uninfected cats. In addition, higher enFeLV loads were found in wildcats compared to domestic cats. The assays described herein are important prerequisites to quantify enFeLV loads and thus to investigate the influence of enFeLV loads on the course of FeLV infection.


Assuntos
DNA Viral/análise , DNA Viral/genética , Dosagem de Genes , Vírus da Leucemia Felina/genética , Polimorfismo Genético , Envelhecimento , Animais , Sequência de Bases , Gatos , Feminino , Masculino , Provírus/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Caracteres Sexuais , Organismos Livres de Patógenos Específicos , Carga Viral
2.
Vet Immunol Immunopathol ; 112(3-4): 141-55, 2006 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-16621029

RESUMO

Natural and experimental feline coronavirus (FCoV) infection leads to systemic viral spread via monocyte-associated viraemia and induces systemic proliferation of monocytes/macrophages. In the majority of naturally infected animals, FCoV infection remains subclinical and is associated with generalised B and T cell hyperplasia, but no other pathological findings. A minority of cats, however, develop feline infectious peritonitis (FIP), a fatal systemic granulomatous disease. This is generally accompanied by B and T cell depletion. The obvious functional differences of lymphatic tissues in FCoV-infected cats with and without FIP suggest that they contribute to the outcome of FCoV infection. This study attempted to evaluate the functional changes in haemolymphatic tissues after natural FCoV infection, with special emphasis on the magnitude, phenotype and function of the monocyte/macrophage population. The spleen, mesenteric lymph nodes and bone marrow from naturally FCoV-infected cats with and without FIP and specific pathogen-free (SPF) control cats were examined for the quantity and activation state of monocytes/macrophages both by immunohistology and by quantitative real time PCR for the transcription of interleukin (IL)-1beta, IL-6, IL-10, IL-12 p40, tumour necrosis factor (TNF), granulocyte colony stimulating factor (G-CSF), macrophage-CSF (M-CSF) and GM-CSF. Compared to cats with FIP, FCoV-infected cats without FIP exhibited significantly higher IL-10 levels in the spleen and significantly lower levels of IL-6, G- and M-CSF in mesenteric lymph nodes. In cats with FIP, however, IL-12 p40 levels were significantly lower in lymphatic tissues in comparison to both SPF cats and FCoV-infected cats without FIP. In comparison to SPF cats, FIP cats had significantly higher IL-1beta levels and lower TNF levels in mesenteric lymph nodes and lower M-CSF levels in the spleen. Findings indicate that FCoV-infected cats which do not develop FIP are able to mount an effective FCoV-specific immune response and can avoid excessive macrophage activation and FIP, possibly by upregulation of IL-10 production. Development of FIP, however, might be due to a lack of IL-12 which inhibits an effective cellular immune response and allows for monocyte/macrophage activation and the development of FIP.


Assuntos
Coronavirus Felino/imunologia , Citocinas/imunologia , Peritonite Infecciosa Felina/imunologia , Animais , Antígenos Virais/imunologia , Medula Óssea/imunologia , Medula Óssea/virologia , Gatos , Citocinas/biossíntese , Citocinas/genética , Peritonite Infecciosa Felina/genética , Peritonite Infecciosa Felina/patologia , Peritonite Infecciosa Felina/virologia , Feminino , Imuno-Histoquímica/veterinária , Linfonodos/imunologia , Linfonodos/virologia , Macrófagos/imunologia , Macrófagos/virologia , Masculino , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa/veterinária , Organismos Livres de Patógenos Específicos , Baço/imunologia , Baço/virologia , Transcrição Gênica
3.
Vaccine ; 24(8): 1087-94, 2006 Feb 20.
Artigo em Inglês | MEDLINE | ID: mdl-16198454

RESUMO

We previously described antigen negative, provirus positive cats. Subsequently, we hypothesized that efficacious FeLV vaccines cannot prevent minimal viral replication. Thus, we vaccinated cats with either a canarypox-vectored live or a killed virus vaccine and analyzed the challenge outcome with quantitative PCR and a newly established real-time RT-PCR. When judged by conventional parameters (antigenaemia, virus isolation), most of the vaccinated cats were, as expected, protected from persistent viraemia. However, all cats were found to be plasma viral RNA positive. The loads were significantly associated with the infection outcome. Thus, commonly used FeLV vaccines understood to be successful model antiretroviral vaccines protecting against FeLV-related diseases do not confer sterilizing immunity.


Assuntos
Vírus da Leucemia Felina/imunologia , Vacinas Virais/imunologia , Animais , Anticorpos Antivirais/sangue , Gatos , Ensaio de Imunoadsorção Enzimática , RNA Viral/sangue , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Vacinação , Carga Viral , Viremia/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA